Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act
Adverse Event Reporting and
Recordkeeping for Dietary Supplements as Required by the Dietary
Supplement and Nonprescription Drug Consumer Protection Act
Extension without change of a currently approved collection
For Dietary Supplements, FDA requires
the manufacturer, packer, or distributor whose name appears on the
label to report all serious adverse event reports associated with
the use of a dietary supplement via the MedWatch form. FDA is
issuing guidance to describe the minimum data elements for serious
adverse event reports for dietary supplements; how, when, and where
to submit a serious adverse event report for a dietary supplement;
and records maintenance and access for serious and non-serious
adverse event reports and related documents.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.